Jump to ContentJump to Main Navigation
India and the Patent WarsPharmaceuticals in the New Intellectual Property Regime$
Users without a subscription are not able to see the full content.

Murphy Halliburton

Print publication date: 2017

Print ISBN-13: 9781501713460

Published to Cornell Scholarship Online: September 2018

DOI: 10.7591/cornell/9781501713460.001.0001

Show Summary Details
Page of

PRINTED FROM Cornell University Press SCHOLARSHIP ONLINE (www.cornell.universitypressscholarship.com). (c) Copyright University of Cornell University Press, 2020. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in Cornell for personal use. date: 27 May 2020

The Gilead Model and the Perspective of Big Pharma

The Gilead Model and the Perspective of Big Pharma

Chapter:
(p.91) 4 The Gilead Model and the Perspective of Big Pharma
Source:
India and the Patent Wars
Author(s):

Murphy Halliburton

Publisher:
Cornell University Press
DOI:10.7591/cornell/9781501713460.003.0005

Here this study takes into account the perspective of multinational pharmaceutical companies. I first discuss the difficulties I encountered in getting access to individuals from pharmaceutical companies who would speak on patent issues and how I was eventually able to speak with representatives from Gilead and Pfizer. Gilead Sciences, a mid-size US-based company, is voluntarily allowing 16 Indian generic pharmaceutical producers to manufacture their drug, tenofovir, a crucial WHO-recommended therapy for HIV/AIDS, and as a result, the price of tenofovir has gone down dramatically. This chapter assesses the meaning of these events and argues that the priority of pharmaceutical companies under the new patent regime is not to get people in poor countries to start paying high drug prices but to protect their markets in wealthy and middle-income countries. The real problem of access under the new patent regime may turn out to be for the poor who live in middle-income countries.

Keywords:   Gilead, tenofovir, Patents Pool, HIV/AIDS medications, pharmaceutical companies, voluntary licenses

Cornell Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.